These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 23653980)

  • 1. Toxic epidermal necrolysis successfully treated with infliximab.
    Zárate-Correa LC; Carrillo-Gómez DC; Ramírez-Escobar AF; Serrano-Reyes C
    J Investig Allergol Clin Immunol; 2013; 23(1):61-3. PubMed ID: 23653980
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of toxic epidermal necrolysis with the combination of infliximab and high-dose intravenous immunoglobulin.
    Gaitanis G; Spyridonos P; Patmanidis K; Koulouras V; Nakos G; Tzaphlidou M; Bassukas ID
    Dermatology; 2012; 224(2):134-9. PubMed ID: 22572593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis and Stevens-Johnson/toxic epidermal necrolysis overlap syndrome. Review of 15 cases].
    Molgó M; Carreño N; Hoyos-Bachiloglu R; Andresen M; González S
    Rev Med Chil; 2009 Mar; 137(3):383-9. PubMed ID: 19621180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beneficial and rapid effect of infliximab on the course of toxic epidermal necrolysis.
    Wojtkiewicz A; Wysocki M; Fortuna J; Chrupek M; Matczuk M; Koltan A
    Acta Derm Venereol; 2008; 88(4):420-1. PubMed ID: 18709327
    [No Abstract]   [Full Text] [Related]  

  • 5. Etanercept for toxic epidermal necrolysis.
    Famularo G; Di Dona B; Canzona F; Girardelli CR; Cruciani G
    Ann Pharmacother; 2007 Jun; 41(6):1083-4. PubMed ID: 17456541
    [No Abstract]   [Full Text] [Related]  

  • 6. Overlap of acute generalized exanthematous pustulosis and toxic epidermal necrolysis: response to antitumour necrosis factor-alpha antibody infliximab: report of three cases.
    Meiss F; Helmbold P; Meykadeh N; Gaber G; Marsch WCh; Fischer M
    J Eur Acad Dermatol Venereol; 2007 May; 21(5):717-9. PubMed ID: 17448012
    [No Abstract]   [Full Text] [Related]  

  • 7. Toxic epidermal necrolysis: retrospective analysis of 21 consecutive cases managed at a tertiary centre.
    Rajaratnam R; Mann C; Balasubramaniam P; Marsden JR; Taibjee SM; Shah F; Lim R; Papini R; Moiemen N; Lewis H
    Clin Exp Dermatol; 2010 Dec; 35(8):853-62. PubMed ID: 20456393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxic epidermal necrolysis associated with high intake of sildenafil and its response to infliximab.
    Al-Shouli S; Abouchala N; Bogusz MJ; Al Tufail M; Thestrup-Pedersen K
    Acta Derm Venereol; 2005; 85(6):534-5. PubMed ID: 16396808
    [No Abstract]   [Full Text] [Related]  

  • 9. Toxic epidermal necrolysis in the setting of systemic lupus erythematosus.
    Konda S; Fernandez AP; Berman B; Elgart G; Milikowski C; Alonso-Llamazares J
    Int J Dermatol; 2011 Oct; 50(10):1270-5. PubMed ID: 21950295
    [No Abstract]   [Full Text] [Related]  

  • 10. Combination therapy of intravenous immunoglobulin and corticosteroid in the treatment of toxic epidermal necrolysis and Stevens-Johnson syndrome: a retrospective comparative study in China.
    Yang Y; Xu J; Li F; Zhu X
    Int J Dermatol; 2009 Oct; 48(10):1122-8. PubMed ID: 19775409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profile and pattern of Stevens-Johnson syndrome and toxic epidermal necrolysis in a general hospital in Singapore: treatment outcomes.
    Tan SK; Tay YK
    Acta Derm Venereol; 2012 Jan; 92(1):62-6. PubMed ID: 21710108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxic epidermal necrolysis 2006.
    Heymann WR
    J Am Acad Dermatol; 2006 Nov; 55(5):867-9. PubMed ID: 17052494
    [No Abstract]   [Full Text] [Related]  

  • 13. Reaction to biological drugs: infliximab for the treatment of toxic epidermal necrolysis subsequently triggering erosive lichen planus.
    Worsnop F; Wee J; Natkunarajah J; Moosa Y; Marsden R
    Clin Exp Dermatol; 2012 Dec; 37(8):879-81. PubMed ID: 22548502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxic epidermal necrolysis-like cutaneous lupus erythematosus: A series of three patients.
    Cisneros CG; Romiti R; Santi CG; Aoki V; Valente NY; Nico MM
    Acta Derm Venereol; 2010 Mar; 90(2):175-8. PubMed ID: 20169302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basic measures and systemic medical treatment of patients with toxic epidermal necrolysis.
    Hanken I; Schimmer M; Sander CA
    J Dtsch Dermatol Ges; 2010 May; 8(5):341-6. PubMed ID: 19845819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxic epidermal necrolysis in systemic lupus erythematosus.
    Horne NS; Narayan AR; Young RM; Frieri M
    Autoimmun Rev; 2006 Feb; 5(2):160-4. PubMed ID: 16431352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxic epidermal necrolysis successfully treated with etanercept.
    Gubinelli E; Canzona F; Tonanzi T; Raskovic D; Didona B
    J Dermatol; 2009 Mar; 36(3):150-3. PubMed ID: 19335689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An update on Stevens-Johnson syndrome and toxic epidermal necrolysis in children.
    Koh MJ; Tay YK
    Curr Opin Pediatr; 2009 Aug; 21(4):505-10. PubMed ID: 19474732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Toxic epidermal necrolysis].
    Alvarez Lovell L
    Actas Dermosifiliogr; 1968; 59(9):579-86. PubMed ID: 4318010
    [No Abstract]   [Full Text] [Related]  

  • 20. Recurrence and outcomes of Stevens-Johnson syndrome and toxic epidermal necrolysis in children.
    Finkelstein Y; Soon GS; Acuna P; George M; Pope E; Ito S; Shear NH; Koren G; Shannon MW; Garcia-Bournissen F
    Pediatrics; 2011 Oct; 128(4):723-8. PubMed ID: 21890829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.